ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer’s Disease

Journal: International Journal of Biomedical Investigation (Vol.1, No. 1)

Publication Date:

Authors : ; ;

Page : 1-18

Keywords : Alzheimer’s disease; PCSK9; LDL; Metabolic diseases;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Alzheimer's disease [AD] is not only the most common neurodegenerative disease but is also currently incurable. Proprotein convertase subtilisin/kexin-9 [PCSK9] is an indirect regulator of plasma low density lipoprotein [LDL] levels controlling LDL receptor expression at the plasma membrane. PCSK9 also appears to regulate the development of glucose intolerance, insulin resistance, abdominal obesity, inflammation, and hypertension, conditions that have been identified as risk factors for AD. PCSK9 levels also depend on age, sex, and ethnic background, factors associated with AD. Herein, we will review indirect evidence that suggests a link between PCSK9 levels and AD

Last modified: 2018-12-30 14:50:08